Element Biosciences

Senior Sales Representative - Boston

Remote

Not SpecifiedCompensation
Senior (5 to 8 years)Experience Level
Full TimeJob Type
UnknownVisa
Biotechnology, Life Sciences, GenomicsIndustries

Requirements

Candidates must possess a Bachelor's degree in Biology or Genetics, or a Master’s or Ph.D. in the same field, and a minimum of four years of commercial experience in sales, marketing, or business development, alongside equivalent laboratory experience and customer-facing skills. Capital equipment sales experience is required, along with a strong foundation in Genetics and Molecular Biology, preferred knowledge of Next Generation Sequencing and Genotyping methods, and deep relationships with decision-makers and researchers in the sequencing and spatial biology community.

Responsibilities

The Senior Sales Representative will develop a thorough understanding of Element’s technology, establish and execute strategies to acquire new customers and maintain/grow existing accounts to meet revenue goals, take an analytical approach to problem-solving and solution development, present versatile solutions during customer negotiations, learn and adapt from experiences to improve sales effectiveness, work effectively within a team to generate revenue opportunities, and manage customer relationships post-sale to foster long-term business partnerships.

Skills

Sales
High-throughput instrument platforms
Consumables sales
Genetics
Molecular Biology
Next Generation Sequencing
Genotyping
Customer Relationship Management
Analytical Skills
Negotiation Skills
Networking
Laboratory Knowledge

Element Biosciences

Next-generation sequencing technology provider

About Element Biosciences

Element Biosciences focuses on next-generation sequencing (NGS) technology, offering the AVITI System, a compact benchtop device that provides high-quality sequencing at a low cost of $1 per million reads. This system is designed for various clients, including academic researchers and pharmaceutical companies, and delivers industry-leading accuracy. Element Biosciences stands out by partnering with other biotech firms, like QIAGEN, to provide complete NGS workflows and by offering the 2023 AVITI for All Grant, which gives free sequencing for diverse applications. The company's goal is to make high-quality sequencing accessible and affordable to accelerate advancements in biotechnology.

Key Metrics

San Diego, CaliforniaHeadquarters
2017Year Founded
$659.5MTotal Funding
SERIES_DCompany Stage
Biotechnology, HealthcareIndustries
201-500Employees

Benefits

100% company-paid medical, dental, & vision coverage
Flexible spending & health savings accounts
Premier mental health care
401(k) with immediately vested 4% company match
Company-paid Life and AD&D insurance
Stock option grants
Flexible time off
10 paid annual holidays
8-weeks paid parental leave

Risks

Increased competition from companies like Illumina may impact market share.
Rapid technological advancements require continuous innovation, straining resources.
High cost of AVITI24 may limit adoption among smaller research institutions.

Differentiation

Element Biosciences offers the AVITI System, a low-cost, high-quality sequencing platform.
The company's proprietary technology improves signal-to-noise ratio, enhancing sequencing data quality.
Strategic partnerships with firms like QIAGEN provide comprehensive NGS workflows for clients.

Upsides

AVITI24 platform integrates sequencing and multiomic analysis, revolutionizing cancer research.
Record growth in AVITI System installations indicates strong market demand and acceptance.
Recent executive appointments highlight commitment to leveraging AI for product optimization.

Land your dream remote job 3x faster with AI